reference/4451429

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/4451429

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	408
issn	0166-3542
issueIdentifier	2
pageRange	403-408
publicationName	Antiviral Research
startingPage	403
bibliographicCitation	Echeverría P, Negredo E, Carosi G, Gálvez J, Gómez JL, Ocampo A, Portilla J, Prieto A, López JC, Rubio R, Mariño A, Pedrol E, Viladés C, del Arco A, Moreno A, Bravo I, López-Blazquez R, Pérez-Alvarez N, Clotet B. Similar antiviral efficacy and tolerability between efavirenz and lopinavir/ritonavir, administered with abacavir/lamivudine (Kivexa), in antiretroviral-naïve patients: a 48-week, multicentre, randomized study (Lake Study). Antiviral Res. 2010 Feb;85(2):403–8. doi: 10.1016/j.antiviral.2009.11.008. PMID: 19941906.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_81295b4b3cf89b65b5d5621e73c77c1b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_601ed3932343f100afb172b314cf19de http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_69f76ca32c3a348808f9db408dc2a968 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_22f4993b57b26f232e10507400c004fc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1bc0da594ce3934d71475d98af8c3156 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5870650900c965668477d92c36841af7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0b35afd38d868e2ec40bd4ec7d3a9163 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_958b148c5f22b0a8e7e9d90152f36a79 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4edab16500a99a9641ce961d19f0431b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f8f5a481e3103baae960723e8aea6801 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0d6e6f300c8a274f5473a634fec5fc82 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b4c31736664a08c1d23ffe86461d7c86 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_94babc249df78e1ecb00bcf5929c7729 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_755049aac50fdab9df82ab04a745d2d9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8f99ad25cf20b33c260ea084f94d4eeb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bbca2c5730d3988e3126091031d58af6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a05cda6c88411f149075503fad86e132 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_294a0854b093e20eb5cba64a82e32a22 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fc566152e31518cb285ab469f1416c33
date	201002
identifier	https://pubmed.ncbi.nlm.nih.gov/19941906 https://doi.org/10.1016/j.antiviral.2009.11.008
isPartOf	https://portal.issn.org/resource/ISSN/0166-3542 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/688
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Similar antiviral efficacy and tolerability between efavirenz and lopinavir/ritonavir, administered with abacavir/lamivudine (Kivexa®), in antiretroviral-naïve patients: A 48-week, multicentre, randomized study (Lake Study)
discusses	http://id.nlm.nih.gov/mesh/M0461882 http://id.nlm.nih.gov/mesh/M0028918 http://id.nlm.nih.gov/mesh/M0019224 http://id.nlm.nih.gov/mesh/M0558541 http://id.nlm.nih.gov/mesh/M0491411 http://id.nlm.nih.gov/mesh/M0000724 http://id.nlm.nih.gov/mesh/M0006823 http://id.nlm.nih.gov/mesh/M0018261 http://id.nlm.nih.gov/mesh/M0023387 http://id.nlm.nih.gov/mesh/M0258297 http://id.nlm.nih.gov/mesh/M0028839 http://id.nlm.nih.gov/mesh/M0005491 http://id.nlm.nih.gov/mesh/M0028682
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D048588Q000627 http://id.nlm.nih.gov/mesh/D019380Q000627 http://id.nlm.nih.gov/mesh/D015658Q000188 http://id.nlm.nih.gov/mesh/D011744Q000627 http://id.nlm.nih.gov/mesh/D019438Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D004342 http://id.nlm.nih.gov/mesh/D004338 http://id.nlm.nih.gov/mesh/D000480 http://id.nlm.nih.gov/mesh/D048588Q000009 http://id.nlm.nih.gov/mesh/D019259Q000009 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D061466 http://id.nlm.nih.gov/mesh/D018791 http://id.nlm.nih.gov/mesh/D011744Q000009 http://id.nlm.nih.gov/mesh/D019562 http://id.nlm.nih.gov/mesh/D028761Q000706 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D015224 http://id.nlm.nih.gov/mesh/D019380Q000009 http://id.nlm.nih.gov/mesh/D003521 http://id.nlm.nih.gov/mesh/D012367Q000097 http://id.nlm.nih.gov/mesh/D019438Q000009
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8096 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_eb6f5112a467cf2f956b874bbf443d46 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11979606 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5273759 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64139 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92727 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9765 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441300 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_68000b5f90a1d5b5b1a93dbb8aa92d3e

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128575040 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128681033 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136283935 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128324017 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129722732

Total number of triples: 91.